Abstract:Our study showed that overexpression of MetBil augmented collagen deposition, cardiac fibroblast proliferation and activation while silencing MetBil exhibited the opposite effects. Heterozygous knockout of MetBil alleviated cardiac fibrosis and improved cardiac function after myocardial infarction. MetBil binding protected METTL3 from ubiquitin modification and promoted METTL3‐mediated m6A modification and expression of fibrosis‐associated genes, therefore resulting in cardiac fibrosis. Cardiac fibrosis is a common pathological manifestation in multiple cardiovascular diseases and often results in myocardial stiffness and cardiac dysfunctions. LncRNA (long noncoding RNA) participates in a number of pathophysiological processes. However, its role in cardiac fibrosis remains unclear. The purpose of this study was to investigate the role and molecular mechanism of MetBil in regulating cardiac fibrosis. Our data showed that METTL3 binding lncRNA (MetBil) was significantly increased both in fibrotic tissue following myocardial infarction (MI) in mice and in cardiac fibroblasts (CFs) exposed to TGF‐β1 (20 ng/mL) or 20% FBS. Overexpression of MetBil augmented collagen deposition, CF proliferation and activation while silencing MetBil exhibited the opposite effects. Importantly, heterozygous knockout of MetBil alleviated cardiac fibrosis and improved cardiac function after MI. RNA pull‐down and RNA‐binding protein immunoprecipitation assay showed that METTL3 is a direct downstream target of MetBil; consistently, MetBil and METTL3 were co‐localized in both the nucleus and cytoplasm of CFs. Interestingly, MetBil regulated METTL3 expression at protein level, but not mRNA level, in ubiquitin–proteasome pathway. Enforced expression of METTL3 canceled the antifibrotic effects of silencing MetBil reflected by increased collagen production, CF proliferation and activation. Most notably, the m6A‐modified fibrosis‐regulated genes mediated by METTL3 are profoundly involved in the regulation of MetBil in the cardiac fibrosis following MI. Our study reveals that MetBil as a novel regulator of fibrosis promotes cardiac fibrosis via interacting with METTL3 and regulating the expression of the methylated fibrosis‐associated genes, providing a new intervening target for fibrosis‐associated cardiac diseases.

METTL3 Boosts Glycolysis and Cardiac Fibroblast Proliferation by Increasing AR Methylation

METTL3 boosts mitochondrial fission and induces cardiac fibrosis by enhancing LncRNA GAS5 methylation

Methyltransferase Like 3-Mediated N6-methylatidin Methylation Inhibits Vascular Smooth Muscle Cells Phenotype Switching Via Promoting Phosphatidylinositol 3-Kinase Mrna Decay.

IGFBP3 epigenetic promotion induced by METTL3 boosts cardiac fibroblast activation and fibrosis

METTL3 silencing suppresses cardiac fibrosis via m6A modification of SMOC2

Fibroblast-specific knockout of METTL1 attenuates myocardial infarction-induced cardiac fibrosis

METTL3 Modulates Radiation-Induced Cardiac Fibrosis via the Akt/mTOR Pathway

Mettl3-mediated m6A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration

Mettl3-mediated m 6 A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration

Mettl3-mediated m<sup>6</sup>A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration

MetBil as a novel molecular regulator in ischemia‐induced cardiac fibrosis via METTL3‐mediated m6A modification

DNA methyltransferase-1 inactivation of androgen receptor axis triggers homocysteine induced cardiac fibroblast autophagy in diabetic cardiac fibrosis.

Abstract 9529: METTL3 Mediates Ang-II Induced Cardiac Hypertrophy Through Accelerating Pri-miR-221/222 Maturation in M6a Way

METTL3 Mediates Ang-II-induced Cardiac Hypertrophy Through Accelerating Pri-Mir-221/222 Maturation in an M6a-Dependent Manner

The M6a Methyltransferase Mettl3 Deficiency Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis

Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury

Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner

METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway

METTL3 Promotes Proliferation and Myogenic Differentiation Through M6a RNA Methylation/ythdf1/2 Signaling Axis in Myoblasts

Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis.

Bidirectional negative feedback actions of DNMT3A and miR-145 in regulating autophagy in cardiac fibroblasts and affecting myocardial fibrosis